Latest
Jan 29, 2021, 03:30 ET FARAPULSE Receives European Approval To Commercialize Its Leading Pulsed Field Ablation System To Treat Paroxysmal Atrial Fibrillation
- FARAPULSE becomes first company in the world to commercialize a cardiac PFA system - MENLO PARK, Calif., Jan. 29, 2021 /PRNewswire/ - FARAPULSE Inc....
Jan 26, 2021, 09:30 ET Nice-Pak Receives EPA Approval for Disinfecting Wipes Use Against Virus Causing COVID-19
Nice-Pak, the pioneer and leading producer of wet wipes for consumer markets, announced that its surface disinfecting wipes (EPA Reg. No. 9480-5)...
Jan 25, 2021, 02:00 ET European Commission Approves BAVENCIO® (avelumab) for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma
EMD Serono, the Healthcare business sector of Merck KGaA, Darmstadt, Germany in the US and Canada, and Pfizer Inc. (NYSE: PFE) today announced that...
Jan 23, 2021, 12:33 ET Menarini obtient l'approbation de la Commission européenne pour l'utilisation d'ELZONRIS (tagraxofusp) dans le traitement du néoplasme des cellules dendritiques plasmacétoïdes blastiques (NCDPB)
Le groupe Menarini, une société privée italienne de produits pharmaceutiques et de diagnostic, a annoncé aujourd'hui que la Commission européenne lui ...
Jan 23, 2021, 09:22 ET Menarini erhält die Zulassung der Europäischen Kommission für ELZONRIS (Tagraxofusp) zur Behandlung von blastischen plasmazytoiden dendritischen Zellneoplasmen (BPDCN)
Die Menarini Group, ein privates italienisches Pharma- und Diagnostikunternehmen, gab heute bekannt, dass die Europäische Kommission (EC) eine...
Jan 22, 2021, 13:56 ET Menarini recibe la aprobación de la Comisión Europea para ELZONRIS (tagraxofusp) para el tratamiento de la neoplasia blástica plasmocitoide de células dendríticas (BPDCN)
El Grupo Menarini, una empresa italiana farmacéutica y de diagnóstico, de capital privado, anunció hoy que la Comisión Europea (CE) ha otorgado la...
Jan 22, 2021, 10:37 ET Menarini recebe aprovação pela Comissão Europeia de ELZONRIS (tagraxofusp) para o tratamento de neoplasia blástica de células dendríticas plasmocitóides (Blastic Plasmacytoid Dendritic Cell Neoplasm, BPDCN)
O Grupo Menarini, uma empresa privada italiana no setor farmacêutico e de diagnóstico, anunciou hoje que a Comissão Europeia (CE) concedeu uma...
Jan 21, 2021, 14:29 ET Menarini recibe aprobación de la Comisión Europea de ELZONRIS para BPDCN
Menarini Group, una empresa farmacéutica y de diagnóstico italiana de propiedad privada, ha anunciado hoy que la Comisión Europea (CE) ha concedido...
Jan 21, 2021, 12:37 ET Bactiguard-coated Zimmer Biomet trauma implants receive European regulatory clearance
Today, Bactiguard-coated Zimmer Biomet orthopaedic trauma implants received European regulatory clearance and CE mark. Preparations for registering...
Jan 21, 2021, 11:36 ET Menarini Receives European Commission Approval of ELZONRIS (tagraxofusp), for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
he Menarini Group, a privately held Italian pharmaceutical and diagnostics company, announced today that the European Commission (EC) has granted a...
Jan 21, 2021, 07:00 ET South Korea's MFDS Approves LUMIFY® Eye Drops
Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), today announced that LUMIFY®...
Jan 19, 2021, 07:00 ET Esaote North America introduces the MyLab™X8 Ultrasound System into Canada: A fully featured, premium imaging system to meet the most demanding clinical needs in the hospital or in the medical office
Esaote North America announces that the MyLab™X8 Ultrasound System has now been approved in Canada. Previously approved by FDA in the USA, MyLab X8...
Jan 17, 2021, 10:19 ET Fundo Russo de Investimento Direto: vacina Sputnik V aprovada no Paraguai
O Fundo Russo de Investimento Direto (RDIF, o fundo soberano da Rússia) anuncia a aprovação da vacina Sputnik V contra o coronavírus pelo Ministério...
Jan 15, 2021, 10:03 ET The Russian Direct Investment Fund: La vacuna Sputnik V, registrada en Paraguay
El Fondo Ruso de Inversión Directa (RDIF, el fondo soberano de la Federación Rusa) anuncia el registro de la vacuna rusa contra el coronavirus...
Jan 13, 2021, 08:00 ET China NMPA Grants Approval for the Registrational Phase 1/2 Clinical Study for GC007g - an Allogeneic CAR-T Cell Therapy for the Treatment of Relapsed or Refractory B-ALL
Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious ...
Jan 12, 2021, 14:15 ET Health Canada approves Lundbeck's (Pr)VYEPTI® (eptinezumab)--the first and only intravenous preventive treatment for migraine
MONTREAL, Jan. 12, 2021 /PRNewswire/ - Lundbeck is pleased to announce that VYEPTI® (eptinezumab) has been approved by Health Canada for the...
Dec 28, 2020, 17:15 ET Présentation de COMIRNATY®, le nom de marque de l'UE pour le vaccin contre la COVID-19 de Pfizer & BioNTech, élaboré par le Brand Institute
Brand Institute, le leader mondial du développement de noms dans le domaine pharmaceutique et des soins de santé, est fier d'annoncer son rôle dans...
Dec 28, 2020, 17:12 ET Einführung von COMIRNATY®, dem EU-Markennamen für den COVID-19-Impfstoff von Pfizer & BioNTech, der vom Brand Institute entwickelt wurde
Brand Institute, das weltweit führende Unternehmen für die Entwicklung von Namen im Pharma- und Gesundheitsbereich, ist stolz darauf, seine Rolle bei ...
Dec 28, 2020, 10:00 ET Introducing COMIRNATY®, the EU Brand Name for Pfizer & BioNTech's COVID-19 Vaccine, Developed by Brand Institute
Brand Institute, the global leader in pharmaceutical and healthcare related name development, is proud to announce its role in naming Pfizer and...
Dec 28, 2020, 10:00 ET Se presenta COMIRNATY®, la vacuna de la COVID-19 de Pfizer y BioNTech, desarrollada por Brand Institute
Brand Institute, líder mundial dentro del desarrollo de nombres relacionados con el área farmacéutica y de cuidado de la salud, se enorgullece al...
Dec 23, 2020, 13:37 ET A Argentina registrou a vacina Sputnik V com base em dados dos ensaios clínicos russos
O Fundo Russo de Investimento Direto (RDIF, fundo soberano da Federação Russa) anuncia o registro da vacina russa Sputnik V contra o coronavírus,...
Dec 23, 2020, 13:24 ET Argentina ha registrado la vacuna Sputnik V en base a los datos de los ensayos clínicos rusos
El Fondo Ruso de Inversión Directa (RDIF, el fondo soberano de la Federación Rusa) anuncia el registro de la vacuna rusa Sputnik V contra el...
Dec 23, 2020, 01:25 ET Halozyme Announces Roche Receives European Commission Approval For Phesgo® (Fixed-Dose Combination Of Perjeta® And Herceptin® For Subcutaneous Injection) Utilizing Halozyme's ENHANZE® Technology For The Treatment Of Patients With HER2-Positive Breast Cancer
Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that the European Commission has approved Roche's Phesgo®, a fixed-dose combination of...
Dec 22, 2020, 23:30 ET Innovent Announces NMPA Granted New Indication Approvals for SULINNO® (Adalimumab Injection) for the Treatment of Pediatric Plaque Psoriasis and Non-infectious Uveitis
Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high...
Dec 18, 2020, 17:21 ET OncoBeta Announces Approval and ARTG Listing of Rhenium-SCT (Rhenium-188 paste) in Australia for the treatment of skin cancer lesions and skin tumors
Garching - OncoBeta® GmbH and their subsidiary OncoBeta Therapeutics Pty Ltd. Australia a Medical Device Company specialized in innovative epidermal...
